If the combination can't be prevented, keep track of teniposide reaction carefully. Take into account therapy modification
butabarbital will lessen the level or influence of lopinavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
butabarbital will minimize the extent or result of diclofenac by influencing hepatic enzyme CYP2C9/10 metabolism. Minor/Importance Unidentified.
butabarbital will decrease the extent or outcome of etravirine by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Observe.
butabarbital will decrease the level or effect of pazopanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
Keep track of Carefully (2)butabarbital will decrease the extent or impact of diazepam intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Powerful or average CYP3A4 inducers might increase price of diazepam elimination; for that reason, efficacy of diazepam may be diminished.
butabarbital will lower the extent or outcome of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Think about a rise in cannabidiol dosage (according to medical response and tolerability) when coadministered check here with a robust CYP3A4 inducer.
Sodium valproate and valproic acid look to decrease barbiturate metabolism; as a result, barbiturate blood stages need to be monitored and suitable dosage changes designed as indicated.
butabarbital will lessen the level or outcome of saquinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
You could get drowsy or dizzy. Do not push, use machinery, or do something that requires psychological alertness right up until you know how this medication influences you.
butabarbital will lessen the extent or effect of pantoprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
butabarbital will lower the extent or impact of amiodarone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
Observe Closely (two)butabarbital will minimize the level or effect of buprenorphine, extensive-performing injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. People who transfer to buprenorphine long-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers should be monitored to be certain buprenorphine plasma degrees are satisfactory.
Along with its necessary results, a medicine could lead to some undesired results. Though not most of these Negative effects may perhaps occur, whenever they do take place They might require healthcare awareness.